JAGX Pangali EV/EBITDA Jaguar Health

Simbol lan logo merek Jaguar Health, Inc. (JAGX)

Jaguar Health, Inc. (JAGX) specializes in developing plant-based treatments for oncology- and HIV-related diarrhea. This price chart illustrates the impact of Mytesi scaling and the expansion of insurance coverage, with the indicator standing at 0.00. The absence of competitors guarantees the issuer significant pricing power over medication costs. Stable raw material supplies from the Amazon and route optimization completely mitigate the risk of logistical disruptions.

JAGX (Jaguar Animal Health) riwayat Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan saka 23.11.2025 nganti 15.11.2026

Rincian metrik lan analitis perusahaan Jaguar Health (JAGX)

- rega saiki lan proyeksi nilai saham:
Analisis dhasar perusahaan:Jaguar Health Corp (JAGX)
Sampel barang jaguar.health

The EV/EBITDA multiple compares the total enterprise value of Jaguar Health, Inc. (JAGX), including net debt, with its operating profit before depreciation and amortization. The current value of 0.00 reflects the company's ability to generate cash flow to service its obligations. Given the absolute non-cyclical nature of demand for Jaguar Health, Inc. (JAGX) maintenance therapy, the company's trend EV/EBITDA level serves as an indicator of the business's fundamental resilience to macroeconomic shocks.